Marinomed Biotech AG (FRA:93Z)
Germany · Delayed Price · Currency is EUR 18.35
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:12 AM CET
Marinomed Biotech AG Market Cap
Marinomed Biotech AG has a market cap or net worth of €35.88 million as of December 1, 2025. Its market cap has increased by 139.51% in one year.
Market Cap
35.88M
Enterprise Value
45.31M
Revenue
9.76M
Ranking
n/a
PE Ratio
3.94
Stock Price
€18.35
Market Cap Chart
Since February 1, 2019, Marinomed Biotech AG's market cap has decreased from 95.76M to 35.88M, a decrease of -62.53%. That is a compound annual growth rate of -13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 36.43M | 36.57% |
| Dec 30, 2024 | 26.67M | -39.87% |
| Dec 29, 2023 | 44.36M | -47.78% |
| Dec 30, 2022 | 84.95M | -34.78% |
| Dec 30, 2021 | 130.25M | -25.67% |
| Dec 30, 2020 | 175.25M | 19.23% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |